The PROPEL™ advantage

How It Works

Innovative yet intuitive.

  • Alt Tag

    PROPEL™ Delivery System is directed to the open surgical cavity.

  • Alt Tag

    The PROPEL implant's spring-like design conforms to patient's unique anatomy and props open the sinus.

  • Alt Tag

    Sustained, local release of mometasone furoate over 30 days.*

  • Alt Tag

    Eventually dissolves.

The PROPEL system leverages Sustained Release Technology, which allows for local, sustained drug delivery directly to the sinus mucosa. Mometasone furoate is embedded in a highly customized polymer, which controls the release of drug over time as the implant dissolves. The self-expanding nature of PROPEL ensures the implant props open the cavity and apposes the tissue to maximize targeted drug delivery.

* Data on file

Step 1

PROPEL™ Delivery System is directed to the open surgical cavity.

Step 2

PROPEL implant's spring-like design conforms to patient's unique anatomy and props open the sinus.

Step 3

Sustained, local release of mometasone furoate over 30 days.*

Step 4

Eventually dissolves.